VIATRIS ILACLARI LTD STI D C

Company Introduction:

VIATRIS ILACLARI LTD STI D C is the Turkish subsidiary of Viatris Inc., a leading global healthcare company. Viatris Inc. was established in 2020 through the combination of Mylan and Upjohn, a former division of Pfizer. The company's mission is to empower people worldwide to live healthier at every stage of life by providing access to high-quality medicines. In Turkey, VIATRIS ILACLARI LTD STI D C focuses on the marketing, sales, and distribution of a diverse portfolio of pharmaceutical products. These products encompass branded generic, complex generic, biosimilar, and over-the-counter medications, addressing a wide range of therapeutic areas. The company plays a crucial role in ensuring the availability of Viatris's global product offerings to patients and healthcare providers across Turkey.

Classification: Trader

Explanation:

VIATRIS ILACLARI LTD STI D C primarily operates as a trader and distributor of pharmaceutical products within the Turkish market. While its parent company, Viatris Inc., is a global pharmaceutical manufacturer with extensive research and production capabilities worldwide, the specific role of the Turkish entity is centered on the sales, marketing, and distribution of these manufactured products to pharmacies, hospitals, and other healthcare channels throughout Turkey. It is not identified as directly operating a manufacturing plant for pharmaceutical production in Turkey under this entity name.

Based on available information, VIATRIS ILACLARI LTD STI D C in Turkey produces or markets products in the following therapeutic areas:

* Cardiovascular

* Central Nervous System

* Dermatology

* Endocrine

* Gastrointestinal

* Infectious Disease

* Oncology

* Pain Management

* Respiratory

* Urology

Please note that this is not an exhaustive list and may not include all products.